Pharmaron Beijing Statistics

Total Valuation

HKG:3759 has a market cap or net worth of HKD 49.27 billion. The enterprise value is 53.42 billion.

Market Cap	49.27B
Enterprise Value	53.42B

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.35%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.14B

Valuation Ratios

The trailing PE ratio is 23.61.

PE Ratio	23.61
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.76, with an EV/FCF ratio of 130.07.

EV / Earnings	25.60
EV / Sales	4.24
EV / EBITDA	19.76
EV / EBIT	33.63
EV / FCF	130.07

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.42.

Current Ratio	1.71
Quick Ratio	1.32
Debt / Equity	0.42
Debt / EBITDA	2.31
Debt / FCF	15.75
Interest Coverage	6.16

Financial Efficiency

Return on equity (ROE) is 13.58% and return on invested capital (ROIC) is 4.79%.

Return on Equity (ROE)	13.58%
Return on Assets (ROA)	4.04%
Return on Invested Capital (ROIC)	4.79%
Return on Capital Employed (ROCE)	7.66%
Revenue Per Employee	643,729
Profits Per Employee	102,814
Employee Count	20,295
Asset Turnover	0.51
Inventory Turnover	7.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.87% in the last 52 weeks. The beta is 0.89, so HKG:3759's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+46.87%
50-Day Moving Average	14.54
200-Day Moving Average	12.21
Relative Strength Index (RSI)	47.63
Average Volume (20 Days)	9,883,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:3759 had revenue of HKD 13.06 billion and earned 2.09 billion in profits. Earnings per share was 1.18.

Revenue	13.06B
Gross Profit	4.46B
Operating Income	1.65B
Pretax Income	2.37B
Net Income	2.09B
EBITDA	2.60B
EBIT	1.65B
Earnings Per Share (EPS)	1.18

Full Income Statement

Balance Sheet

The company has 2.88 billion in cash and 6.47 billion in debt, giving a net cash position of -3.59 billion.

Cash & Cash Equivalents	2.88B
Total Debt	6.47B
Net Cash	-3.59B
Net Cash Per Share	n/a
Equity (Book Value)	15.54B
Book Value Per Share	8.38
Working Capital	3.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.76 billion and capital expenditures -2.35 billion, giving a free cash flow of 410.68 million.

Operating Cash Flow	2.76B
Capital Expenditures	-2.35B
Free Cash Flow	410.68M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 34.12%, with operating and profit margins of 12.61% and 15.97%.

Gross Margin	34.12%
Operating Margin	12.61%
Pretax Margin	18.13%
Profit Margin	15.97%
EBITDA Margin	19.88%
EBIT Margin	12.61%
FCF Margin	3.14%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.31%.

Dividend Per Share	0.22
Dividend Yield	1.31%
Dividend Growth (YoY)	-33.08%
Years of Dividend Growth	n/a
Payout Ratio	29.13%
Buyback Yield	-0.06%
Shareholder Yield	1.25%
Earnings Yield	4.24%
FCF Yield	0.83%

Dividend Details

Stock Splits

The last stock split was on July 18, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 18, 2023
Split Type	Forward
Split Ratio	1.5

Scores

HKG:3759 has an Altman Z-Score of 3.7.

Altman Z-Score	3.7
Piotroski F-Score	n/a